Surgical Sutures Market Size & Share 2025 - 2034

Surgical Sutures Market Size

The global surgical sutures market size was valued at USD 4.7 billion in 2024. The market is anticipated to grow from USD 4.9 billion in 2025 to USD 8.4 billion in 2034, growing at a CAGR of 6.1% from 2025 to 2034. A catalyst for market growth is the rising geriatric population globally and the increased rate of surgeries for age related conditions such as hernia repair, orthopedic procedures and many more.

High growth in the market can be attributed to the increasing volume of surgical procedures, spurred by rising incidence of chronic diseases and lifestyle-related health complications such as cardiovascular disorders, diabetes, and obesity. According to WHO as reported in 2021, cardiovascular diseases (CVDs) are the leading cause of death globally which are responsible for 17.9 million deaths in 2019. This makes surgical intervention more prevalent.
 

Furthermore, availability of advanced medical surgical tools, rapid growth in minimally invasive surgeries, and continuous innovation in suture materials such as synthetic absorbable sutures are further escalating the market expansion. For example, a report released by the National Institutes of Health (NIH) in 2023 indicates that minimally invasive surgery (MIS) has transformed the surgical treatment landscape and improved patient outcomes. Together these factors are expected to create strong momentum in the market over the next decade.
 

The surgical suture market refers to the production and sale of medical threads used for closing wounds and surgical incision. These sutures are critical in all types of surgeries, ensuring optimal wound healing and minimizing postoperative complications.
 

Surgical Sutures Market Trends

• The increasing number of non-communicable disease account for 75% of global deaths as reported by WHO in 2024. With the increase in the number of cardiovascular diseases, diabetes, obesity fueling surgical procedures, the need for sutures in healthcare has increased, thereby driving the demand for surgical sutures.
   
• Additionally, the rising burden of surgeries is also escalating the surgical suture market. An estimated 143 million additional surgeries are required annually in the low- and middle-income countries to meet the essential care needs.
   
• Expanding infrastructure to deliver these procedures is expected to fuel the procurement of surgical sutures.
   
• Moreover, surgeon are adopting advanced sutures to reduce infection related complications, which is increasing the demand for coated surgical sutures. It is observed that antibacterial coated sutures can reduce surgical site infection rate by 40%, prompting surgeons to select premium suture types for infection control.
   
• This shift towards the heightened focus on infection prevention continues to escalate the demand for both traditional and innovative suturing solutions across medical specialties.
   
• Further, the use of barbed sutures, that are designed using unidirectional and bidirectional barbes, has also increased. Barbed sutures eliminate the need for know tying and helps to reduce the closure time. These sutures are preferred during minimally invasive surgical procedures, cosmetic procedures, laparoscopic procedures, and gynecological procedures.
   
• With enhancements in suture materials, the use of biocompatible sutures is increasing, which are made using  bioabsorbable suture materials such as silk-alginate blends, polyglycolic acid, polyglactin, and polydioxanone. These materials promote tissue healing and avoids follow-up procedures to remove sutures.
   

Surgical Sutures Market Analysis

In 2021, the global market was valued at USD 4 billion. The following year, it saw a slight increase to USD 4.2 billion, and by 2023, the market further climbed to USD 4.4 billion. Based on product type, the global market is segmented into absorbable sutures and non-absorbable sutures. The absorbable segment accounted for the highest market share and was valued at USD 3 billion in 2024.
 

• Absorbable sutures are highly valued for their ability to degrade naturally within the body tissues over time, eliminating the need for manual removal.
   
• This reduces the follow-up visits and enhances patient comfort, especially in procedures involving internal organs and soft tissues.
   
• These sutures are preferred in pediatric and internal surgeries for minimizing patient discomfort and infection risks. According to CDC about 32.6 million outpatient surgical procedures were conducted in U.S. hospitals in 2021 many of them were internal tissue repair which simultaneously boost the usage of absorbable sutures.
   
• The segment's high market share is also driven by growing awareness of minimal invasive surgery and the increasing prevalence of chronic diseases.

Learn more about the key segments shaping this market

Download Free PDF

Based on the filament, the global surgical sutures market is categorized into monofilament and multifilament. The multifilament segment dominated the market with 63.8% market share in 2024.
 

• The dominance of this segment is attributed to the superior knot security, flexibility and ease of handling offered by these multifilament sutures.
   
• Multifilament sutures are composed of multiple strands twisted or braided together, which enhances their tensile strength. These properties make them preferred choice in procedures demanding precision and strong tissue approximation.
   
• These are widely used in general, orthopedic, gastrointestinal, gynecological surgeries, especially where rapid tissue closure and reliable knotting are essential.
   
• Their popularity is further bolstered by their performance. Moreover, brands such as Vicryl, that is polyglactin 90, continue to dominate the hospitals due to their predictable absorption profile, strong initial tensile strength retention and superior wound support during the critical healing phase. Owing to these reasons, the multifilament surgical sutures are expected to maintain a favorable market position in the foreseeable future.
   

Based on application, the global surgical sutures market is categorized into ophthalmic, gynecology, cardiology, orthopedics, neurological surgeries, and other surgeries. The cardiac surgery segment dominated the market and is anticipated to grow at a CAGR of 6.5%.
 

• The significant share of this segment is escalating due to the rising global burden of cardiovascular diseases (CVDs) which remain the leading cause of death worldwide. According to WHO, as reported in 2024, CVDs accounted for 32% of all global deaths in 2019, many of which require surgical intervention.
   
• The increasing prevalence of coronary artery disease, valvular heart disease, and congenital heart defect has led to a steady rise in the number of open heart and minimally invasive cardiac procedures. For instance, as reported by CDC in 2024, more than 944,800 people in the U.S. are reported dead due to heart disease or stroke every year. This necessitates the use of durable, biocompatible surgical sutures for vessel and tissue approximation.
   
• Furthermore, increasing healthcare access, expansion of cardiovascular care infrastructure in emerging economies and growing elderly population are key contributing factors in the segment’s expansion.
   

Based on end use, the global surgical sutures market is classified into hospitals, speciality clinics, ambulatory surgical centers, and other end users. In 2024, the hospitals segment held highest market share and is expected to showcase significant growth over the analysis period.
 

• Hospitals remain the primary end users of surgical sutures due to the high volume of inpatient and outpatient surgeries performed in these settings.
   
• For instance, in OECD member countries there were approximately 130 hospital discharges per 1000 population in 2021, reflecting high procedural volumes.
   
• Also, the availability of advanced surgical infrastructure, including hybrid operating rooms and robotic surgical system reinforces hospitals’ reliance on different types of sutures for different procedures.
   
• The segment also benefits from higher surgeon concentration and skilled staff availability, which stimulates the use of premium and specialty sutures.
   
• Moreover, in emerging markets increasing public healthcare investments and infrastructure expansion are also supporting hospital segments growth.

The North America surgical sutures market dominated the global surgical suture market in 2024, valuing at USD 2 billion. The market dominance is attributed to the high volume of surgical procedures performed in U.S. and Canada, and widespread availability of advanced healthcare infrastructure.
 

The U.S. surgical suture market was valued at USD 1.6 billion and USD 1.7 billion in 2021 and 2022, respectively. The market size reached USD 1.9 billion in 2024, growing from USD 1.8 billion in 2023.
 

• The U.S. is home to 6,093 hospitals as reported by the American Hospital Association, many of which are equipped with state of art operating rooms, fostering the use of conventional and advance suturing technologies.
   
• Additionally, the healthcare expenditure per capita in the U.S. surpassed USD 12,000 in 2023, which translates to significant spending on surgical tools and wound closure materials further fueling the market expansion.
   
• Moreover, the presence of leading market players such as Ethicon (Johnson & Johnson), Medtronic, and Teleflex along with strong distribution networks ensures rapid access to advanced surgical sutures.
   

Europe surgical sutures market accounted for USD 1.2 billion in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Rising incidences of age-related surgical procedures and increasing chronic disease prevalence continues to increase demand for surgical sutures in Europe.
   
• Government across Europe are investing heavily in upgrading infrastructure including modern operating rooms which simultaneously increases hospitals procurement of advanced surgical sutures.
   
• Also, the presence of key market players in the region reinforces Europe’s strength in the market. The vendors are actively participating in innovation through the development of innovative solutions, further aiding to market growth.
   

Germany market is anticipated to witness considerable growth over the analysis period.
 

• The country’s well-established healthcare practices and research institutions, along with their emphasis on high-quality medical equipment, contribute to the widespread adoption of surgical sutures.
   
• The demand for advanced suture material is rising as healthcare providers increasingly aim to reduce post-operative complications such as surgical site infections (SSI) and support faster recovery.
   
• The country ranks among the highest in Europe for surgical procedures. Hip and knee replacement are among the most common surgeries which require high strength durable sutures for wound closure. In 2022, Germany recorded 326.2 hip replacement procedures per 100,000 inhabitants. This indicates an aging orthopedic patient population, that directly contributes to suture consumption.
   
• Additionally, Germany’s role as a hub for innovation further solidifies its position as a leader in the market, catering to both domestic and international demand for reliable and efficient solutions.
   

The Asia Pacific surgical sutures market is anticipated to grow at the highest CAGR of 6.7% during the analysis timeframe.
 

• The market in the Asia Pacific region is growing rapidly due to the growing burden of chronic diseases such as cancer, cardiovascular diseases, gastrointestinal diseases. The treatment for these diseases require surgical interventions, driving the demand for surgical sutures in the region.
   
• Countries like China, India and Japan are at the forefront of this trend, contributing significantly to the rising procedural volume.
   
• In Japan, the high proportion of elderly population is linked with increases demand for surgical procedures. For example, in 2023 projections from the World Economic Forum revealed that 1 in 10 people in Japan are aged 80 years and above which was about one-third of the population.
   
• Additionally, as healthcare standards continue to rise in the region, the need for innovative technologies are further expected to propel the market for surgical sutures in the region.
   

China surgical suture market is predicted to grow significantly over the forecast period.
 

• High inpatient and surgical throughput support suture usage. Chinese hospitals recorded a substantial volume of inpatient procedures which elevated the demand for surgical sutures.
   
• China’s aging population drive orthopedic and cardiovascular suturing needs. With 18% population aging 60 and above in 2021, there has been a high demand for surgeries which is boosting consumption of both absorbable and non-absorbable sutures.
   
• Furthermore, the presence of a large number of local manufacturers in the country such as Jinhuan Medical, WEGO Surgical Sutures, and  Shanghai Pudong Jinhuan Medical Products also helps to enhance market growth.
   

Brazil is experiencing significant growth in the Latin America surgical sutures market due to the increasing demand for advanced surgical sutures in healthcare.
 

• Brazil has high volume of private hospitals which enhances demand for surgical procedures. With the major percentage of hospitals being private and known for performing high share of surgical procedures, there is steady demand for premium  and specialized suture products across the private sector.
   
• Additionally, the presence of  dual healthcare system, Sistema Único de Saúde (SUS), that offers free access to surgical care, is also supporting an increase in surgical volume in Brazil, further aiding to the market growth.
   

Saudi Arabia surgical sutures market is poised to witness substantial growth in Middle East and Africa market during the forecast period.
 

• The growing surgical procedure volume supports suture demand. According to the Ministry of Health (MOH), 177,744 routine surgeries were performed in MOH hospitals during the first half of 2023.
   
• High volume surgical specialties stimulate material variety. Among 2023 procedures 21% were general surgeries, 14% were obstetrics, creating diverse demand for absorbable and non-absorbable sutures.
   
• Further, hospital expansion under Vision 2030 initiative also helps to boost surgical capacity. The MOH is investing heavily in infrastructure, increasing capacity and surgical throughput, which in turn raises the procurement of advanced suture materials.
   

Surgical Sutures Market Share

Competition in the surgical suture industry is marked by well-established companies, regional manufacturer and emerging firms. The top five companies, Ethicon (Johnson & Johnson), Medtronic, B.Braun Melsungen AG, Smith & Nephew, Healthium Medtech accounts for 40% of the global market share. These key players focus on various strategies such as acquisitions, business expansion, new launches to sustain their competitive edge.
 

Additionally, there are several local and regional players operating in the market who are boosting competition by providing affordable options at lower costs. These players are also involved in several strategies such as mergers, acquisitions, and novel product launches to expand their product offerings.
 

Surgical Sutures Market Companies

Few of the prominent players operating in the surgical sutures industry include:

• Advanced Medical Solutions
• B. Braun Melsungen
• Boston Scientific
• CONMED
• Corza Medical
• Dolphin Sutures
• Ethicon (Johnson & Johnson)
• GPC Medical
• Healthium Medtech
• Integra Lifesciences
• Kono Seisakusho
• Medtronic
• Peters Surgical
• Smith and Nephew
• Stryker
• Teleflex
• Zimmer Biomet
   
• Ethicon (Johnson & Johnson) is a dominant player in the global surgical market, known for its wide range of absorbable and non- absorbable sutures used across various surgical specialties.
   
• Medtronic holds a significant share in the surgical suture market through its comprehensive surgical solutions portfolio. Medtronic emphasizes R&D and product development offerings specialty sutures with enhances tensile strength and handling properties.
   
• Teleflex provides sutures known for consistent tensile strength and reliability. Teleflex has well recognized suture brands such as the Quill Knotless Tissue-Closure Device, that are highly regarded for its innovative closure solutions.
   

Surgical Suture Industry News

• In March 2024, Advanced Medical Solutions Group plc, one of the key player in tissue-healing technologies, announced that it has reached an agreement to acquire Peters Surgical, a prominent global name in specialty surgical sutures, mechanical haemostasis, and internal cyanoacrylate devices.
   
• In October 2024, Corza Medical, a leading player in the global medical technology scene, announced to roll out its new line of Onatec ophthalmic microsurgical sutures. This launch was showcased at the American Academy of Ophthalmology (AAO) conference held in Chicago.
   
• In September 2023, Genesis MedTech, a leading medical device company, announced that its absorbable sutures with antibacterial protection have successfully obtained approval from the China's National Medical Products Administration (NMPA) for market release.
   
• In August 2023, Healthium Medtech, a global leader in medical technology solutions, announced that the company has launched TRUMASTM, a range of sutures meticulously designed to address challenges faced during suturing in minimal access surgeries.
   

The surgical sutures market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Absorbable sutures
  • Natural sutures
  • Synthetics sutures
• Non absorbable sutures
  • Nylon
  • Prolene

Market, By Filament

• Monofilament
• Multifilament

Market, By Application

• Opthalmic surgery
• Cardiac surgery
• Orthopaedic surgery
• Neurological surgery
• Gynaecology surgery
• Other surgeries

 Market, By End Use

• Hospitals
• Ambulatory surgical centres
• Specialty clinics
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE